Literature DB >> 14513076

Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes.

K H Liu1, Y L Chan, W B Chan, W L Kong, M O Kong, J C N Chan.   

Abstract

OBJECTIVE: Visceral fat, notably mesenteric fat, which is drained by the portal circulation, plays a critical role in the pathogenesis of metabolic syndrome through increased production of free fatty acids, cytokines and vasoactive peptides. We hypothesize that mesenteric fat thickness as measured by ultrasound scan could explain most of the obesity-related health risk. We explored the relationships between cardiovascular risk factors and abdominal fat as determined by sonographic measurements of thickness of mesenteric, preperitoneal and subcutaneous fat deposits, total abdominal and visceral fat measurement by magnetic resonance imaging (MRI) and anthropometric indexes.
DESIGN: A cross-sectional study.
SUBJECTS: Subjects included 18 healthy men and 19 women (age: 27-61 y, BMI: 19-33.4 kg/m(2)). MEASUREMENTS: The maximum thickness of mesenteric, preperitoneal and subcutaneous fat was measured by abdominal ultrasound examination. MRI examinations of whole abdomen and pelvis were performed and the amount of total abdominal and visceral fat was quantified. The body mass index, waist circumference and waist-hip ratio were recorded. Cardiovascular risk factors were assessed by physical examination and blood taking.
RESULTS: Men had more adverse cardiovascular risk profile, higher visceral fat volume and thicker mesenteric fat deposits than women. Among all the investigated obesity indexes, the mesenteric fat thickness showed the highest correlations with total cholesterol, LDL-C, triglycerides, fasting plasma glucose, HbA(1c) and systolic blood pressure in men, and with triglycerides and HbA(1c) in women. On stepwise multiple regression analysis with different obesity indexes as independent variables, 30-65% of the variances of triglycerides, total cholesterol, LDL-C and HbA(1c) in men, and triglycerides in women were explained by the mesenteric fat thickness.
CONCLUSION: Compared with sonographic measurement of subcutaneous and preperitoneal fat thickness, MRI measurement of total abdominal and visceral fat and anthropometric indexes, sonographic measurement of mesenteric fat thickness showed better associations with some of the cardiovascular risk factors. It may potentially be a useful tool to evaluate regional distribution of obesity in the assessment of cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513076     DOI: 10.1038/sj.ijo.0802398

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  26 in total

1.  Ultrasound evaluation of visceral and subcutaneous fat reduction in morbidly obese subjects undergoing laparoscopic gastric banding, sleeve gastrectomy, and Roux-en-Y gastric bypass: a prospective comparison study.

Authors:  Ido Mizrahi; Nahum Beglaibter; Natalia Simanovsky; Natali Lioubashevsky; Haggi Mazeh; Muhammad Ghanem; Katya Chapchay; Ahmed Eid; Ronit Grinbaum
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

2.  Fully automatic and nonparametric quantification of adipose tissue in fat-water separation MR imaging.

Authors:  Defeng Wang; Lin Shi; Winnie C W Chu; Miao Hu; Brian Tomlinson; Wen-Hua Huang; Tianfu Wang; Pheng Ann Heng; David K W Yeung; Anil T Ahuja
Journal:  Med Biol Eng Comput       Date:  2015-08-06       Impact factor: 2.602

3.  Thickness estimation of the subcutaneous fat using coaxial probe.

Authors:  Mohammad Hossein Ramezani; Esmaeil S Nadimi
Journal:  Healthc Technol Lett       Date:  2016-02-24

Review 4.  HIV-associated lipodystrophy: impact of antiretroviral therapy.

Authors:  Giovanni Guaraldi; Chiara Stentarelli; Stefano Zona; Antonella Santoro
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

5.  Major depression, borderline personality disorder, and visceral fat content in women.

Authors:  Wiebke Greggersen; Sebastian Rudolf; Eva Fassbinder; Leif Dibbelt; Beate M Stoeckelhuber; Fritz Hohagen; Kerstin M Oltmanns; Kai G Kahl; Ulrich Schweiger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-26       Impact factor: 5.270

6.  Comparison of dual-energy x-ray absorptiometric and anthropometric measures of adiposity in relation to adiposity-related biologic factors.

Authors:  Qi Sun; Rob M van Dam; Donna Spiegelman; Steven B Heymsfield; Walter C Willett; Frank B Hu
Journal:  Am J Epidemiol       Date:  2010-10-15       Impact factor: 4.897

7.  Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects.

Authors:  Rebecca Scherzer; Wei Shen; Peter Bacchetti; Donald Kotler; Cora E Lewis; Michael G Shlipak; Steven B Heymsfield; Carl Grunfeld
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

8.  Attenuation of age-related metabolic dysfunction in mice with a targeted disruption of the Cbeta subunit of protein kinase A.

Authors:  Linda C Enns; John F Morton; Ruby Sue Mangalindan; G Stanley McKnight; Michael W Schwartz; Matt R Kaeberlein; Brian K Kennedy; Peter S Rabinovitch; Warren C Ladiges
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-09-23       Impact factor: 6.053

9.  Sonographic assessment of abdominal fat distribution in infancy.

Authors:  Susanne Holzhauer; Renate M L Zwijsen; Vincent W V Jaddoe; Guenther Boehm; Henriette A Moll; Paul G Mulder; Veronica A Kleyburg-Linkers; Albert Hofman; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009-07-29       Impact factor: 8.082

10.  Impact of Early Infant Growth, Duration of Breastfeeding and Maternal Factors on Total Body Fat Mass and Visceral Fat at 3 and 6 Months of Age.

Authors:  Laura M Breij; Marieke Abrahamse-Berkeveld; Dennis Acton; Emanuella De Lucia Rolfe; Ken K Ong; Anita C S Hokken-Koelega
Journal:  Ann Nutr Metab       Date:  2017-11-14       Impact factor: 3.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.